These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17552392)

  • 1. Epiretinal deposit of triamcinolone acetonide at the posterior pole after intravitreal injection.
    Jaissle GB; Szurman P; Völker M; Bartz-Schmidt KU
    Ophthalmic Surg Lasers Imaging; 2007; 38(3):238-41. PubMed ID: 17552392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole.
    Yamamoto N; Ozaki N; Murakami K
    Ophthalmologica; 2004; 218(4):248-56. PubMed ID: 15258413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular hole closure following intravitreal triamcinolone injection in a previously vitrectomized diabetic eye.
    Kumar V; Ghosh B; Raina UK; Goel N
    Acta Ophthalmol; 2010 Jun; 88(4):e128. PubMed ID: 19843015
    [No Abstract]   [Full Text] [Related]  

  • 4. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triamcinolone-associated crystalline maculopathy.
    Sarraf D; Vyas N; Jain A; Bui A; Kertes PJ; Freund KB; Chan C
    Arch Ophthalmol; 2010 Jun; 128(6):685-90. PubMed ID: 20547944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
    Imasawa M; Ohshiro T; Gotoh T; Imai M; Iijima H
    Acta Ophthalmol Scand; 2005 Feb; 83(1):132-3. PubMed ID: 15715582
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
    Choi YJ; Oh IK; Oh JR; Huh K
    Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.
    Chin HS; Park TS; Moon YS; Oh JH
    Retina; 2005; 25(5):556-60. PubMed ID: 16077349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling].
    Jaissle GB; Bartz-Schmidt KU; Szurman P
    Ophthalmologe; 2008 Jun; 105(6):575-7. PubMed ID: 17955246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
    Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
    Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular hole closure following intravitreal triamcinolone injection in a previously vitrectomized diabetic eye.
    Kwon YH; Chung H; Kim JG; Yoon YH
    Acta Ophthalmol; 2009 Feb; 87(1):111-2. PubMed ID: 18507730
    [No Abstract]   [Full Text] [Related]  

  • 15. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
    Aggermann T; Stolba U; Brunner S; Binder S
    Ophthalmologica; 2006; 220(2):131-3. PubMed ID: 16491037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
    Retina; 2005; 25(7):846-50. PubMed ID: 16205562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double visualization using triamcinolone acetonide and trypan blue during stage 3 macular hole surgery.
    Yamamoto N; Ozaki N; Murakami K
    Ophthalmologica; 2004; 218(5):297-305. PubMed ID: 15334009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
    Quiram PA; Gonzales CR; Schwartz SD
    Am J Ophthalmol; 2006 Mar; 141(3):580-2. PubMed ID: 16490518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.